ACCEL

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

[Ac-225]-PSMA-62 (mCRPC)OngoingActive not recruitingPhase 1Open NCT06229366 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…